RevitaLens Ocutec Multi-purpose Disinfecting Solution provides high-quality disinfection of silicone hydrogel and conventional soft contact lenses
ABBOTT PARK, Ill., Sept. 29 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) market clearance for RevitaLens Ocutec™, a unique next-generation multi-purpose disinfecting solution for silicone hydrogel and conventional soft contact lenses.
RevitaLens Ocutec Multi-purpose Disinfecting Solution delivers high-quality disinfection and comfort for the user, with the convenience of a single bottle. The solution was developed in cooperation with world class silicone hydrogel, microbiology and chemistry experts and with input from more than 600 eyecare professionals.
"This advanced, next-generation solution establishes a new standard of disinfecting technology for contact lens wearers," said Jim Mazzo, senior vice president, Abbott Medical Optics. "Proper contact lens care, including a rub and rinse regimen using RevitaLens Ocutec, will help patients achieve clean and comfortable lenses while enhancing overall lens-wearing satisfaction."
It is estimated that there are 125 million contact lens wearers worldwide. Multi-purpose solutions (MPS) represent the majority of systems used for the care of soft contact lenses. These comprise a single solution for the rinsing, cleaning, disinfection and storage of lenses and are typically composed of a preservative, buffer system and other agents to aid in lens cleaning and comfort.
Key characteristics of RevitaLens Ocutec Multi-purpose Disinfecting Solution include:
- high microorganism kill rates;
- removes proteins from the lens surface;
- effectively kills Acanthamoeba and Fusarium;
- reduces corneal staining;
- minimizes risk of eye complications.
"It is gratifying to see the contact lens solution industry developing new products, such as RevitaLens Ocutec, that enhance patient safety by providing the delicate balance of superior disinfection, comfort and convenience," said Dr. Thomas Quinn, an optometrist in Athens, Ohio.
Abbott plans to begin retail shipment of RevitaLens Ocutec Multi-purpose Disinfecting Solution in the U.S. this October. The product also has CE Mark approval in Europe.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at www.abbott.com.